Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Storb

Showing results (811-820 of 899) with videos related to

Pageof 90
Sort By:
Leukemia|March 18, 2005
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantationF Baron, M B Maris, B E Storer, et al.
Blood|August 1, 1981
Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatmentR P Witherspoon, R Storb, H D Ochs, et al.
Blood|December 12, 2001
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trialE Kansu, T Gooley, M E Flowers, et al.
Blood|December 1, 1988
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission durationP J Martin, R A Clift, L D Fisher, et al.
Bone Marrow Transplantation|July 1, 1992
Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I studyF B Petersen, C D Buckner, F R Appelbaum, et al.
Transplantation|September 1, 1979
Marrow transplantation from donors other than HLA-identical siblingsR A Clift, J A Hansen, E D Thomas, et al.
Lancet (London, England)|September 18, 1982
Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantationR A Clift, C D Buckner, E D Thomas, et al.
Bone Marrow Transplantation|November 1, 1989
Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I studyF B Petersen, C D Buckner, F R Appelbaum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 1, 1996
Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivorsH P Kiem, G B McDonald, D Myerson, et al.
The New England Journal of Medicine|January 14, 1982
Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twinsA Fefer, M A Cheever, P D Greenberg, et al.
Pageof 90

Showing results (811-820 of 899) with videos related to

Sort By:
Pageof 90
Leukemia|March 18, 2005
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantationF Baron, M B Maris, B E Storer, et al.
Blood|August 1, 1981
Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatmentR P Witherspoon, R Storb, H D Ochs, et al.
Blood|December 12, 2001
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trialE Kansu, T Gooley, M E Flowers, et al.
Blood|December 1, 1988
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission durationP J Martin, R A Clift, L D Fisher, et al.
Bone Marrow Transplantation|July 1, 1992
Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I studyF B Petersen, C D Buckner, F R Appelbaum, et al.
Transplantation|September 1, 1979
Marrow transplantation from donors other than HLA-identical siblingsR A Clift, J A Hansen, E D Thomas, et al.
Lancet (London, England)|September 18, 1982
Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantationR A Clift, C D Buckner, E D Thomas, et al.
Bone Marrow Transplantation|November 1, 1989
Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I studyF B Petersen, C D Buckner, F R Appelbaum, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 1, 1996
Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivorsH P Kiem, G B McDonald, D Myerson, et al.
The New England Journal of Medicine|January 14, 1982
Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twinsA Fefer, M A Cheever, P D Greenberg, et al.
Pageof 90